Quality of Life of TEP vs Lichtenstein Hernioplasty

The Comparison of the Quality of Life and Outcomes in Patient's With Reducible Inguinal Hernias: Laparoscopic Totally Extra-peritoneal (TEP) Versus Modified Lichtenstein Hernioplasty

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02723045

Enrollment

100

Registered

2016-03-30

Start date

2016-04-30

Completion date

2017-09-30

Last updated

2016-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Brief summary

To determine if there is a difference in the quality of life in between patients who undergoes laparoscopic totally extra-peritoneal (TEP) or modified Lichtenstein hernioplasty

Detailed description

Patients presenting with reducible inguinal hernias will be randomized between open or laparoscopic repair groups. The primary outcome will be the quality of life scores. Patients will be followed-up for 12 months.

Interventions

PROCEDUREOpen Lichtenstein Hernioplasty

PROCEDURELaparoscopic TEP Hernioplasty

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years of age and older * Both genders * Unilateral inguinal hernias * Reducible inguinal hernias * Elective setting

Exclusion criteria

* ASA Physical Status (American Society of Anaesthesiologists) Grade \> 2 * Recurrence * Inguinal-scrotal hernias * Prostatectomy, Pfannenstiel incision, previous pre-peritoneal surgery * Pregnancy * Refusal for general anaesthesia

Design outcomes

Primary

Measure	Time frame	Description
Quality of life	12 months	Carolina Comfort Scale

Secondary

Measure	Time frame	Description
Operating time	12 months	—
Duration of hospitalization	12 months	—
Complications	12 monthts	—
Recurrence	12 months	Recurrence of hernia after repair

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026